Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Saturday, April 21, 2018 · 443,319,435 Articles · 3+ Million Readers

Aviv Biomedical Announces Launch of New Website for their AVIV-BHS Bilirubin Hematofluorometer

Aviv Biomedical


LAKEWOOD, NEW JERSEY, USA, February 20, 2018 / -- Lakewood, New Jersey, 14 January 2018 – Aviv Biomedical proudly announces the launch of its new website at showcasing the AVIV-BHS Bilirubin Hematofluorometer System, for assessment of jaundice in newborn babies. The new website explains the principles of operation for Aviv’s latest instrument which is currently in clinical trials at a leading US hospital.

The AVIV-BHS instrument allows, for the first time, the rapid measurement in neonates of Bilirubin Binding Capacity (BBC), a critical factor in preventing or allowing the development of neonatal jaundice. Bilirubin is neurotoxic, and high levels following birth can result in grave illnesses including seizures, cerebral palsy and kernicterus.

Aviv is working with The Sage Group to identify a partner with whom it will roll out its ground-breaking AVIV-BHS globally.

Florence Aviv, Aviv’s President, stated, “We are delighted to announce the launch of our new website,, for this ground-breaking new instrument from Aviv, allowing assessment of risk of neonatal jaundice with high accuracy. This capability should transform neonatal treatment with huge economic benefits for healthcare systems worldwide. Our main priority now is to identify one or more global partners with whom Aviv can work to roll out the AVIV-BHS as widely as possible.”

About Aviv Biomedical
Aviv Biomedical (“Aviv”) is a leading edge medical instrumentation developer. It was founded in 1971 by the late Jack Aviv in Lakewood NJ USA, initially to service spectrophotometers, circular dichroism spectrometers and spectrofluorometers. The company is a family-owned enterprise run today by the Aviv family.

Since 1971, Aviv Biomedical has strived to provide the best scientific instruments and support possible. The product line includes a ZPP hematofluorometer for whole blood screening for iron deficiency and lead poisoning. Aviv strives to produce an unparalleled medical instrument capability and provide superior service.

For more information about Aviv Biomedical and partnering opportunities for the AVIV-BHS, please contact:
Dr. Bill Mason
The Sage Group
The Old Black Barns
Lord’s Lane, Ousden CB8 8TX UK
Tel: +44 (0) 7785 950134

Dr. Bill Mason
The Sage Group
+44 7785 950134
email us here

Powered by EIN Presswire